Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 May 12.
Published in final edited form as: Ann Neurol. 2013 May 9;74(3):472–477. doi: 10.1002/ana.23884

Nicotine from edible Solanaceae and risk of Parkinson disease (ANA-12-1625)

Susan Searles Nielsen 1, Gary M Franklin 1, WT Longstreth Jr 2,3, Phillip D Swanson 2, Harvey Checkoway 1,3
PMCID: PMC4864980  NIHMSID: NIHMS454255  PMID: 23661325

Abstract

Objective

To test whether risk of Parkinson disease (PD) is associated with consumption of nicotine-containing edibles from the same botanical family as tobacco, Solanaceae, including peppers, tomatoes and potatoes.

Methods

In a population-based study with 490 newly diagnosed idiopathic PD cases diagnosed during 1992–2008 at the University of Washington Neurology Clinic or Group Health Cooperative in western Washington State and 644 unrelated, neurologically normal controls, we examined whether PD was associated with self-reported typical frequency of consumption of peppers, tomatoes, tomato juice and potatoes during adulthood, while adjusting for consumption of other vegetables, age, sex, race/ethnicity, tobacco use and caffeine.

Results

PD was inversely associated with consumption of all edible Solanaceae combined (relative risk [RR]=0.81, 95% confidence interval [CI] 0.65–1.01 per time per day), but not consumption of all other vegetables combined (RR=1.00, 95% CI 0.92–1.10). The trend strengthened when we weighted edible Solanaceae by nicotine concentration (ptrend=0.004). An inverse association was also evident for peppers specifically (ptrend=0.005). The potentially protective effect of edible Solanaceae largely occurred in men and women who had never used tobacco or who had smoked cigarettes <10 years.

Interpretation

Dietary nicotine or other constituents of tobacco and peppers may reduce PD risk. However, confirmation and extension of these findings is needed to strengthen causal inferences that could suggest possible dietary or pharmaceutical interventions for PD prevention.

MeSH Key Words: Anatabine, bell pepper, Capsicum, diet, idiopathic Parkinson disease, potatoes, nicotine, Solanaceae, tomatoes, TRPV1 receptors

Introduction

The most consistent findings from epidemiologic research on environmental factors and Parkinson disease (PD) have been reduced risks related to cigarette smoking and use of other forms of tobacco.1 Exposure to environmental tobacco smoke may possibly confer protection as well.24 Nonetheless, it remains unresolved whether nicotine or other constituents of tobacco smoke are truly protective, or rather, that failure to smoke indicates preclinical behavioral differences in persons predisposed to develop PD.

Several mechanisms by which tobacco smoking might reduce PD risk have been hypothesized. Tobacco smoke contains thousands of chemicals, but notably, experimental studies indicate that nicotine is neuroprotective.5 Nicotine is the addictive phytochemical in tobacco, which is derived from plants in the Nicotiana species of the Solanaceae family. Other species in this family include Capsicum and Solanum, whose edible fruits and tubers include peppers, tomatoes, potatoes and eggplants. All contain nicotine.610 The amount of nicotine absorbed from these foods is negligible relative to the amount obtained from active smoking, and probably lower than that from environmental tobacco smoke.11 However, even nicotine blood levels reached from environmental tobacco smoke exposure, much lower than that from active smoking, are sufficient to saturate a substantial portion of α4β2 nicotine receptors in the human brain.12 Stimulation of nicotine receptors protects dopaminergic neurons in animal models of PD using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)13 or rotenone.14 Therefore, given the strength of the association we recently observed between PD and environmental tobacco smoke, which was similar to that for active smoking,2 we investigated whether nicotine from dietary sources might also demonstrate an inverse association with PD in the same case-control study population.

Methods

Study population

We conducted a population-based case-control study in western Washington State.1516 Briefly, cases (N=490) were newly diagnosed with idiopathic PD at Group Health Cooperative, a health maintenance organization in the Puget Sound region (GHC, N=387), or the University of Washington Neurology Clinic (N=103) in Seattle in 1992–2008. Diagnoses were made by movement disorder specialists or were verified by consensus chart reviews performed by a team of neurologists (GMF, WTL, PDS). All cases had ≥2 of 4 cardinal signs of PD (bradykinesia, resting tremor, cogwheel rigidity, postural reflex impairment). Exclusion criteria were 1) an established cause of secondary parkinsonism (e.g., stroke, brain tumor, selected medications), 2) enrollment >4 years after diagnosis, or 3) abnormal (<24) Mini-Mental State Examination (MMSE) score. We identified controls (N=644) from among GHC enrollees who were frequency matched to cases on sex, age (within 10 years), race/ethnicity, clinic and year of GHC enrollment. Controls were 1) cognitively normal (MMSE ≥24), 2) without PD, Alzheimer disease, multiple sclerosis or other neurodegenerative disorders, and 3) unrelated by blood or marriage to cases.

Assessment of Solanaceae exposure

We administered a standardized in-person questionnaire to assess dietary and tobacco use histories. We defined tobacco use as ever smoking >100 cigarettes, or ever regularly using cigars, pipes or smokeless tobacco. The questionnaire, a modified version of the Willet food frequency questionnaire as of 1991, elicited information on typical frequency of consumption during adulthood of 71 foods and beverages covering all major food groups and sources of caffeine.1718 Complete tobacco and diet histories were obtained for 486 (99%) of cases and 636 (99%) of controls.

The Solanaceae family edibles we assessed were peppers, tomatoes, tomato juice and potatoes (baked or mashed). We also assessed consumption of other vegetables: broccoli, cauliflower, cabbage, Brussels sprouts, radishes, lettuce, spinach/other greens, carrots, peas/lima beans, corn, sweet potatoes/yams, cucumbers, zucchini, yellow/winter squash and onions/scallions. Participants reported frequency of consumption of each in one of nine categories (almost never, 1–3 times/month, 1/week, 2–4/week, 5–6/week, daily, 2–3/day, 4–6/day, 6+/day). We weighted these responses according to the relative frequency per day, and then summed them to obtain combined measures of frequency of consumption of: 1) all edible Solanaceae and 2) all other vegetables. In addition, we created a variable for the former in which we also weighted by nicotine concentration of the individual Solanaceae foods. We used results from the most sensitive comprehensive laboratory analysis of nicotine in edible Solanaceae published to date.6 Specifically, we used the median dry-weight nicotine concentration for all measurements of foods as they would be consumed, because water content and ripening, and possibly peeling and cooking, affect nicotine content. We included all measurements for peppers (median 102.1 µg nicotine/kg). For tomatoes we only included measurements for fresh, ripe tomatoes (degree of ripening 7–12, median 43.8 µg nicotine/kg). For tomato juice (not included in the laboratory assessment), we used all measurements for processed tomato products (median 29.7 µg nicotine/kg). For potatoes we used measurements only for cooked potatoes (median 19.25 µg nicotine/kg). The median nicotine level for eggplant was below the limit of quantification.

Statistical analyses

We performed unconditional logistic regression analysis to calculate odds ratios and 95% confidence intervals (CIs) as an estimate of relative risk (RR) of PD in relation to edible Solanaceae. We adjusted for frequency matching variables age, sex and race/ethnicity, as well as for frequency of consumption of all non-Solanaceae vegetables combined, tobacco products (ever vs. never regular use) and caffeine (mg,19 continuous) because smoking and caffeine are associated with PD1 and dietary patterns.2022 We also verified the absence of confounding (<10% change in relative risk estimates) by extent of cigarette smoking (years, packs per day, pack years, recentness), consumption of alcohol (drinks per day), other individual foods and food groups, estimated alternate Mediterranean Diet Score,23 education, birth year, urban vs. rural residence, and family history of PD in the full dataset; and body mass index (at age 20 and at interview) and environmental tobacco smoke exposure at home and work in 154 cases and 173 controls for whom those data were available.2

Because the amount of nicotine from active tobacco use would likely eclipse that from dietary sources, we repeated all analyses stratified by tobacco use (ever vs. never smoked >100 cigarettes or regularly used pipes, cigars or smokeless tobacco). We formally tested any potential interactions between PD, edible Solanaceae and tobacco use in logistic regression on a multiplicative scale with main effects terms in the model.

Results

Participant characteristics have been described previously.16 Briefly, most cases and controls were non-Hispanic Caucasians (93% and 92%, respectively) and were men (63% and 64%, respectively). Cases’ mean age was 65.6 years at diagnosis, and controls’ was 68.0 years at reference. Relatively few cases (11%) and controls (5%) had a first-degree relative with PD. Half of cases and 62% of controls had ever smoked tobacco products, and among ever cigarette smokers, controls smoked more than cases by several measures, including mean duration of years smoked (22.5 for cases, 26.8 for controls).

Frequency of consumption of edible Solanaceae (peppers, tomatoes, tomato juice and potatoes combined) was inversely related to PD risk (ptrend = 0.07, Table 1). In contrast, we observed no association with the frequency of consumption of all other vegetables combined (ptrend = 0.95). The inverse PD-Solanaceae association strengthened when we weighted by nicotine concentration (ptrend = 0.004). There was only a suggestion of an inverse trend for tomatoes and tomato juice, and no inverse association for potatoes, but there was a strong inverse association for peppers (ptrend = 0.005). We confirmed a dose-response association in an unconstrained model: Eating peppers 2–4 times or more per week was consistently associated with a ≥ 30% reduction in risk for developing PD (Table 2). The potentially protective effects of edible Solanaceae in general, or peppers specifically, were very similar in men and women (Supplemental Table 1), but were mainly evident in men and women who had never used tobacco regularly or who had smoked cigarettes <10 years (Tables 1 and 2; Supplemental Table 2). However, interactions between PD, edible Solanaceae/peppers and tobacco use were not statistically significant (all pinteraction ≥ 0.15).

Table 1.

Parkinson disease risk and edible Solanaceaea and other vegetables, overall and by tobacco useb


All participants
486 cases/
636 controls
RR (95% CI)c
Ever used
tobaccob
245 cases/
397 controls
RR (95% CI)c

Never used tobacco
241 cases/
239 controls
RR (95% CI)c
Edible Solanaceaea 0.81 (0.65–1.01) 0.89 (0.68–1.17) 0.69 (0.47–1.00)
ptrend 0.07 0.42 0.05
Nicotined-weighted ptrend 0.004 0.23 0.002
  Pepper (102.1 µg/kg nicotined) 0.43 (0.24–0.78) 0.66 (0.30–1.44) 0.24 (0.09–0.60)
  Tomato (43.8 µg/kg nicotined) 0.83 (0.56–1.24) 1.00 (0.61–1.66) 0.58 (0.30–1.14)
  Tomato juice (29.7 µg/kg nicotined) 0.77 (0.41–1.44) 0.54 (0.24–1.21) 2.16 (0.56–8.36)
  Potato (19.25 µg/kg nicotined) 1.12 (0.73–1.70) 1.25 (0.72–2.18) 0.91 (0.47–1.76)
  Eggplant (µg/kg nicotine<LOQd,e) NAf NAf NAf
Other vegetablesg 1.00 (0.92–1.10) 0.99 (0.88–1.11) 1.03 (0.90–1.18)
ptrend 0.95 0.84 0.63
a

All assessed edible Solanaceae: green, yellow or red peppers, tomatoes, tomato juice, and baked or mashed potatoes

b

Ever smoked >100 cigarettes or regularly used cigars, pipes or smokeless tobacco

c

Relative risk (odds ratio) and 95% confidence interval, per once daily increase in typical adult life frequency of consumption, adjusted for age (continuous), sex, race/ethnicity, consumption of other vegetables (continuous) and caffeine (mg, continuous); and adjustment for or stratification by tobacco use (ever vs. never >100 cigarettes or regularly used cigars, pipes or smokeless tobacco)

d

Median dry-weight nicotine concentration in each Solanaceae as typically consumed (e.g. ripe tomatoes and cooked potatoes), derived from Siegmund et al. 1999

e

Detected but below the limit of quantification

f

Not assessed

g

All assessed non-Solanaceae vegetables combined: broccoli, cauliflower, cabbage, Brussels sprouts, radishes, lettuce, spinach/other greens, carrots, peas/lima beans, corn, sweet potatoes/yams, cucumbers, zucchini, yellow/winter squash and onions/scallions

Table 2.

Parkinson disease risk and peppers, overall and by tobacco usea

Consumption
of peppers
All participants Ever used tobaccoa Never used tobacco
Cases
N=486
n (%)
Controls
N=636
n (%)
RR (95% CI)b Cases
N=245
n (%)
Controls
N=397
n (%)


RR (95% CI)b
Cases
N=241
n (%)
Controls
N=239
n (%)


RR (95% CI)b
< Weekly 283 (58) 333 (52) 1.0 (reference) 146 (60) 219 (55) 1.0 (reference) 137 (57) 114 (48) 1.0 (reference)
1/week 103 (21) 120 (19) 0.95 (0.69–1.31) 47 (19) 70 (18) 1.02 (0.65–1.58) 56 (23) 50 (21) 0.92 (0.57–1.47)
2–4/week 78 (16) 130 (20) 0.70 (0.50–1.00) 39 (16) 80 (20) 0.77 (0.48–1.23) 39 (16) 50 (21) 0.59 (0.35–0.99)
5–6/week 12 (2) 29 (5) 0.48 (0.23–0.99) 5 (2) 13 (3) 0.70 (0.23–2.09) 7 (3) 16 (7) 0.37 (0.14–1.00)
Daily 10 (2) 24 (4) 0.50 (0.22–1.15) 8 (3) 15 (4) 0.88 (0.34–2.31) 2 (1) 9 (4) 0.13 (0.02–0.73)
ptrend 0.005 0.30 0.003
a

Ever >100 cigarettes or regularly used cigars, pipes or smokeless tobacco

b

Relative risk (odds ratio) and 95% confidence interval for typical adult life frequency of consumption of green, yellow or red peppers, adjusted for age (continuous), sex, race/ethnicity, consumption of tomatoes, tomato juice, potatoes, other vegetables and caffeine (continuous), and adjustment for or stratification by tobacco use (ever vs. never >100 cigarettes or regularly used cigars, pipes or smokeless tobacco)

Discussion

Epidemiologic studies have reported inverse associations of PD with consumption of tomatoes,24 potatoes25 and a “Mediterranean” diet high in vegetables including tomatoes and peppers.23,26 However, to our knowledge, this is the first study of PD focused on dietary nicotine or consumption of Solanaceae other than tobacco. Similar to the well-established inverse association between PD and tobacco use, we observed an inverse association between PD and edible Solanaceae, especially peppers. We observed no inverse association between PD and combined frequency of consumption of non-Solanaceae vegetables, indicating some specificity of the association. Furthermore, the PD-Solanaceae association was largely confined to men and women who never used tobacco or only did so for a relatively short period.

Some caution in interpreting these results is required. Relative to active tobacco use, diet is a modest contributor to daily nicotine dose, and biological effects on the human brain from dietary nicotine from edible Solanaceae are not established. It is known, however, that a substantial number of α4β2 nicotine receptors become occupied at nicotine blood levels achieved without active smoking; and that one-third of the receptors are occupied for >3 hours by a single cigarette puff, whereas complete saturation is only achieved after multiple cigarettes.12 This biological effect of a relatively small amount of nicotine may offer some supporting evidence for a neuroprotective effect of nicotine from diet.

We also note that tomatoes and potatoes are probably more important than peppers with regard to the absolute amount of nicotine ingested,11 yet the PD-Solanaceae association we observed was largely due to peppers. An absence of data on foods such as tomato-based sauces and salsas, and boiled and fried potatoes including chips and French fries, may have muted associations for tomatoes and potatoes. In addition, because of first-pass metabolism of nicotine in the liver, perhaps ingested nicotine is required to be obtained from a concentrated source in order to reach the brain. The dry-weight concentration of nicotine may be substantially greater in peppers than in tomatoes and potatoes.67

Finally, constituents of peppers other than nicotine may be neuroprotective. Given the possible interaction between PD, peppers and tobacco use, shared phytochemicals are of particular interest. Another alkyloid, anatabine, is an intriguing possibility because it has anti-inflammatory properties2729 and might be more feasibly employed as a neuroprotective chemical than nicotine due to its longer half-life and perhaps lower toxicity and addictive potential. Alternatively, capsinoids in peppers and capsaicinoids in spicy peppers activate transient receptor potential cation channel subfamily vanilloid member 1 (TRPV1) receptors.30 These receptors are in the substantia nigra, and they and capsaicin may affect survival of midbrain dopaminergic neurons.3132 Given the relatively weak results for tomatoes, it is unlikely that lycopene or vitamins A and C account for our findings.

The strength of our study comes from the use of newly diagnosed cases and a highly comparable control group unrelated to cases by blood or marriage. The main limitation is that we obtained diet data retrospectively by self-report, and we did not assess diet for different periods of life. Although we inquired about typical consumption in adulthood, PD or its medical correlates may affect diet33 and therefore may have influenced our results somewhat. For the possible inverse associations we report here, heartburn is of greatest concern. Constipation and dysphagia are unlikely to underlie the associations. More detailed assessment of diet for different periods of life also would have improved our ability to focus on the effect of dietary nicotine in the years without active tobacco use. An additional limitation is the lack of environmental tobacco smoke exposure data for most participants.

Epidemiological studies designed to address these limitations, while retaining the considerable strengths of the present work, may shed further light on our somewhat novel hypothesis and findings. Although they are consistent with the well established inverse association between PD and tobacco use, it remains unknown whether nicotine reduces PD risk and whether TRPV1 agonists, including those in peppers, are neuroprotective or neurotoxic.3132 Replication of our findings will be needed to strengthen causal inferences that might eventually lead to dietary or pharmaceutical interventions designed to help prevent PD.

Supplementary Material

1

Acknowledgements

This work was sponsored in part by University of Washington Superfund Research Program, Grant # NIEHS P42ES004696. Additional funding was provided by NIEHS R01ES10750.

H.C. obtained funding. H.C., G.M.F., W.T.L., and P.D.S. obtained data and made critical revisions to the text. S.S.N. had full access to the data, conducted statistical analysis, wrote the manuscript and takes full responsibility for the article.

Potential Conflicts of Interest

All authors: grants/grants pending, NIH.

References

  • 1.Wirdefeldt K, Adami HO, Cole P, et al. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011;26(Suppl 1):S1–S58. doi: 10.1007/s10654-011-9581-6. [DOI] [PubMed] [Google Scholar]
  • 2.Searles Nielsen S, Gallagher LG, Lundin JI, et al. Environmental tobacco smoke and Parkinson's disease. Mov Disord. 2012;27:293–296. doi: 10.1002/mds.24012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.O’Reilly EJ, Chen H, Gardener H, et al. Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. Am J Epidemiol. 2009;169:678–682. doi: 10.1093/aje/kwn388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mellick GD, Gartner CE, Silburn PA, Battistutta D. Passive smoking and Parkinson disease. Neurology. 2006;67:179–180. doi: 10.1212/01.wnl.0000223618.53129.56. [DOI] [PubMed] [Google Scholar]
  • 5.Quik M, Perez XA, Bordia T. Nicotine as a potential neuroprotective agent for Parkinson's disease. Mov Disord. 2012;27:947–957. doi: 10.1002/mds.25028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Siegmund B, Leitner E, Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999;47:3113–3120. doi: 10.1021/jf990089w. [DOI] [PubMed] [Google Scholar]
  • 7.Sheen SJ. Detection of nicotine in foods and plant material. J Food Sci. 1988;53:1572–1573. [Google Scholar]
  • 8.Castro A, Monji D. Dietary nicotine and its significance in studies on tobacco smoking. Biochem Arch. 1986;2:91–97. [Google Scholar]
  • 9.Davis RA, Stiles MF, deBethizy JD, et al. Dietary nicotine: a source of urinary cotinine. Food Chem Toxicol. 1991;29:821–827. doi: 10.1016/0278-6915(91)90109-k. [DOI] [PubMed] [Google Scholar]
  • 10.Domino EF, Hornbach E, Demana T. Relevance of nicotine content of common vegetables to the identification of passive tobacco smokers. Med Sci. Res. 1993;21:571–572. [Google Scholar]
  • 11.Andersson C, Wennström P, Gry J. Nicotine alkaloids in Solanaceous food plants. Copenhagen: Nordic Council of Ministers; 2003. [Google Scholar]
  • 12.Brody AL, Mandelkern MA, London ED, et al. Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Arch Gen Psychiatry. 2006;63:907–915. doi: 10.1001/archpsyc.63.8.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Liu Y, Hu J, Wu J, et al. α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. J Neuroinflammation. 2012;9:98. doi: 10.1186/1742-2094-9-98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Takeuchi H, Yanagida T, Inden M, et al. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models. J Neurosci Res. 2009;87:576–585. doi: 10.1002/jnr.21869. [DOI] [PubMed] [Google Scholar]
  • 15.Checkoway H, Powers K, Smith-Weller T, et al. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol. 2002;155:732–738. doi: 10.1093/aje/155.8.732. [DOI] [PubMed] [Google Scholar]
  • 16.Searles Nielsen S, Checkoway H, Butler RA, et al. LINE-1 DNA methylation, smoking and risk of Parkinson’s disease. J Parkinsons Dis. 2012;2:303–308. doi: 10.3233/JPD-012129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Powers KM, Smith-Weller T, Franklin GM, et al. Dietary fats, cholesterol and iron as risk factors for Parkinson's disease. Parkinsonism Relat Disord. 2009;15:47–52. doi: 10.1016/j.parkreldis.2008.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Willett WC. Nutritional epidemiology. New York: Oxford University Press; 1990. [Google Scholar]
  • 19.Gebhardt SE, Thomas RG. Nutritive values of foods. Beltsville, Maryland: U.S. Department of Agriculture (USDA) Agricultural Research Service (ARS) Home and Garden Bulletin Number 72; 2002. [Google Scholar]
  • 20.Dallongeville J, Marécaux N, Fruchart JC, et al. Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J Nutr. 1998;128:1450–1457. doi: 10.1093/jn/128.9.1450. [DOI] [PubMed] [Google Scholar]
  • 21.Haibach JP, Homish GG, Giovino GA. A longitudinal evaluation of fruit and vegetable consumption and cigarette smoking. Nicotine Tob Res. 2013;15:355–363. doi: 10.1093/ntr/nts130. [DOI] [PubMed] [Google Scholar]
  • 22.Osler M, Kjaer SK. Determinants of smoking behaviour in random samples of Greenlandic and Danish women 20–39 years of age. Arctic Med Res. 1996;55:62–68. [PubMed] [Google Scholar]
  • 23.Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007;86:1486–1494. doi: 10.1093/ajcn/86.5.1486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Fall PA, Fredrikson M, Axelson O, et al. Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden. Mov Disord. 1999;14:28–37. doi: 10.1002/1531-8257(199901)14:1<28::aid-mds1007>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  • 25.Hellenbrand W, Seidler A, Boeing H, et al. Diet and Parkinson's disease. I: A possible role for the past intake of specific foods and food groups. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology. 1996;47:636–643. doi: 10.1212/wnl.47.3.636. [DOI] [PubMed] [Google Scholar]
  • 26.Alcalay RN, Gu Y, Mejia-Santana H, et al. The association between Mediterranean diet adherence and Parkinson's disease. Mov Disord. 2012;27:771–774. doi: 10.1002/mds.24918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Caturegli P, De Remigis A, Ferlito M, et al. Anatabine ameliorates experimental autoimmune thyroiditis. Endocrinology. 2012;153:4580–4587. doi: 10.1210/en.2012-1452. [DOI] [PubMed] [Google Scholar]
  • 28.Paris D, Beaulieu-Abdelahad D, Bachmeier C, et al. Anatabine lowers Alzheimer's Aβ production in vitro and in vivo. Eur J Pharmacol. 2011;670:384–391. doi: 10.1016/j.ejphar.2011.09.019. [DOI] [PubMed] [Google Scholar]
  • 29.Paris D, Beaulieu-Abdelahad D, Ait-Ghezala G, et al. Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation. Eur J Pharmacol. 2013;698:145–153. doi: 10.1016/j.ejphar.2012.11.017. [DOI] [PubMed] [Google Scholar]
  • 30.Sasahara I, Furuhata Y, Iwaski Y, et al. Assessment of the biological similarity of three capsaicin analogs (capsinoids) found in non-pungent chili pepper (CH-19 Sweet) fruits. Biosci Biotechnol Biochem. 2010;74:274–278. doi: 10.1271/bbb.90570. [DOI] [PubMed] [Google Scholar]
  • 31.Kim SR, Lee DY, Chung ES, et al. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. J Neurosci. 2005;25:662–671. doi: 10.1523/JNEUROSCI.4166-04.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Park ES, Kim SR, Jin BK. Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress. Brain Res Bull. 2012;89:92–96. doi: 10.1016/j.brainresbull.2012.07.001. [DOI] [PubMed] [Google Scholar]
  • 33.Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord. 2009;24:1881–1892. doi: 10.1002/mds.22705. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES